Derek Cridebring
Impact in
-
- Cancer Genomics and Diagnostics
-
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Oncology 9
- Pancreatic and Hepatic Oncology Research 7
- Lung Cancer Research Studies 2
- Co-authors
- Daniel D. Von Hoff (10 shared papers)Osamu Kano (2 shared papers)Ken Ikeda (2 shared papers)Yasuo Iwasaki (2 shared papers)Haiyong Han (6 shared papers)Takanori Takazawa (1 shared paper)Yasuhiro Yoshii (1 shared paper)Wei Lin (1 shared paper)
- Journals
- Cancer Research (2 papers)Aging (2 papers)The Oncologist (2 papers)British Journal of Cancer (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Derek Cridebring
16 papers receiving 337 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 95
- Oncology 151
- Neurology 82
- Immunology 56
- Molecular Biology 153
Countries citing papers authored by Derek Cridebring
This map shows the geographic impact of Derek Cridebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Cridebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Cridebring more than expected).
Fields of papers citing papers by Derek Cridebring
This network shows the impact of papers produced by Derek Cridebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Cridebring. The network helps show where Derek Cridebring may publish in the future.
Co-authors
The 25 scholars most cited alongside Derek Cridebring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 161 | |
| 2 | 2011 | 80 | |
| 3 | 2022 | 26 | |
| 4 | 2013 | 20 | |
| 5 | 2020 | 13 | |
| 6 | 2021 | 10 | |
| 7 | 2012 | 7 | |
| 8 | 2020 | 5 | |
| 9 | 2025 | 4 | |
| 10 | 2011 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2021 | 2 | |
| 14 | 2019 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2025 | 0 |
About Derek Cridebring
Derek Cridebring is a scholar working on Oncology, Geriatrics and Gerontology, Modeling and Simulation, Cancer Research and Neurology, having authored 17 papers that have together received 342 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), MicroRNA in disease regulation (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Circular RNAs in diseases (2 papers), Lung Cancer Research Studies (2 papers), Extracellular vesicles in disease (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Cancer Research (95 citations), Oncology (151 citations), Neurology (82 citations), Immunology (56 citations) and Molecular Biology (153 citations). Derek Cridebring has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Daniel D. Von Hoff, Osamu Kano, Ken Ikeda, Yasuo Iwasaki, Haiyong Han, Takanori Takazawa, Yasuhiro Yoshii, Wei Lin, Gayle Jameson and Jin Seok Heo. Their work appears in journals such as Cancer Research, Aging, The Oncologist, British Journal of Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.